Core Stabalization and Rebound Therapy and CP

Balance Clinical Trial

Official title:

Effect of Core Stabalization Versus Rebound Therapy on Balance in Children With Cerebral Palsy

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT05739396
• Other study ID #: P.T.REC/012/003117
• Status: Active, not recruiting
• Phase: N/A
• Start date: February 1, 2023
• Est. completion date: July 11, 2023

Study information

• Verified date: February 2023
• Source: Cairo University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

the study aims to compare the effect of core stabalization and rebound therapy on balance in children with hemiplegic cerebral palsy

Description:

PURPOSE:

To compare the effect of core stabilization and rebound therapy on balance in children with hemiplegic cerebral palsy

BACKGROUND:

Cerebral palsy is primarily a disorder of movement and posture

HYPOTHESES:

There is no significant difference between core stabilization and rebound therapy on balance in children with hemiplegic cerebral palsy.

RESEARCH QUESTION:

Is there a significant difference between core stabilization and rebound therapy on balance in children with hemiplegic cerebral palsy?

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 26
• Est. completion date: July 11, 2023
• Est. primary completion date: June 1, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 5 Years to 8 Years

Eligibility

Inclusion Criteria:

• children diagnosed with spastic hemiplegic CP.

• Their chronological age ranged from 5 to 8 years,

• able to follow verbal commands or instructions during testing procedures,

• degree of spasticity in affected lower limbs ranged between1 to 1+ according to Modified Ashworth scale (MAS),

• they are able to understand and follow instructions given to them,

Exclusion Criteria:

• Children who had significant visual or auditory problems that may interfere with testing, - ---- patients who had contractures or fixed deformities related to the joints of the lower limbs, ---- injection with Botulinium toxin or any orthopaedic surgery in lower limbs 6m before study,

• children who were suffering from cardiopulmonary problems or epilepsy.

Related Conditions & MeSH terms

• Balance
• cp
• Whole Body Vibration

Intervention

Other:
• core stabilization
The treatment session lasted one hour with short breaks of around 10 minutes and will be conducted three times per week for twelve successive weeks

Locations

Country	Name	City	State
Egypt	Faculty Of Physical Therapy	Cairo

Sponsors (1)

Lead Sponsor	Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	balance	it measures the degree of tilting for each axis during dynamic conditions and calculates a medial lateral stability index (MLSI); an anterior-posteriorstability index (APSI); and an overall stability index(OSI),	12 week
Secondary	gross motor function measure-88	measure gross motor function. higher scores indicate better outcome. scores are reported in percentage.	12 week
Secondary	lafayette hand held dynamometer	measure isometric muscle strength of knee flexors and extensors. higher scores reflect better outcome	12 week
Secondary	6 minute walk test	measure endurance.	12 week